Antibodies that neutralize SIVmac251 in T lymphocytes cause interruption of the viral life cycle in macrophages by preventing nuclear import of viral DNA

Virology

Volumn 287, Issue 2, 2001, Pages 436-445

  Zhuge, Wu ^a   Jia, Fenglan ^a   Mackay, Glenn ^a   Kumar, Anil ^a   Narayan, Opendra ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

AIDS; Antibody; HIV; Macrophage; Neutralization; Nuclear transport; SIV

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; MONOCLONAL ANTIBODY; PROTEIN KK17; PROTEIN KK42; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS DNA; VIRUS ENVELOPE PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANTIBODY RESPONSE; ARTICLE; CELL ADHESION; CELL TRANSPORT; CONTROLLED STUDY; DNA DETERMINATION; GENE AMPLIFICATION; IMMUNIZATION; INOCULATION; LIFE CYCLE; MACROPHAGE; MONKEY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE; VIROGENESIS; VIRUS NEUTRALIZATION; VIRUS REPLICATION;

ANIMALIA; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0035450962     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2001.1053     Document Type: Article

References (45)

1. Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera
2. Mechanisms of protection induced by attenuated simian immunodeficiency virus. IV. Protection against challenge with virus grown in autologous simian cells
3. CCR5 signal transduction in macrophages by human immunodeficiency virus and simian immunodeficiency virus envelopes
4. Inoculation of baboons and macaques with simian immunodeficiency virus/Mne, a primate lentivirus closely related to human immunodeficiency virus type 2
5. Prevention of HIV-2 and SIVSM infection in cynomolgus monkeys by active or passive immunization
6. The antibody response in HIV-1 infection
7. Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usage
8. Effects of natural sequence variation on recognition by monoclonal antibodies neutralize simian immunodeficiency virus infectivity
9. Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus
10. Prevention of HIV infection by passive immunization with HIVIG or CD4-IgG
11. Prevention of HIV-1 infection in chimpanzees by gp120 V3 domain-specific monoclonal antibody
12. Neutralizing antibodies administered before but not after virulent SHIV prevent infection in macaques
13. Passive immunization of rhesus macaques against SIV infection and disease
14. Passive immune globulin therapy in the SIV/macaque model: Early intervention can alter disease profile
15. Neutralization of HIV-1 primary isolates by polyclonal and monoclonal human antibodies
16. Serum enhancement of human immunodeficiency virus (HIV) infection correlates with disease in HIV-infected individuals
17. mac239 during persistent infection in a rhesus macaque
18. Production and of monoclonal antibodies to simian immunodeficiency virus envelope glycoproteins
19. Passive immunization of cynomolgus macaques with immune sera or a pool of neutralizing monoclonal antibodies failed to protect against challenge with SIVmac251
20. Identification of two neutralizing and 8 nonneutralizing epitopes on simian immunodeficiency virus envelope using monoclonal antibodies
21. Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus
22. Neutralizing antibodies in sera from macaques immunized with attenuated simian immunodeficiency virus
23. Passively transferred antibodies directed against conserved regions of SIV envelope protect macaques from SIV infection
24. Protection of macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies
25. Potent and synergistic neutralization of human immunodeficiency virus (HIV) type 1 primary isolates by hyperimmune anti-HIV immunoglobulin combined with monoclonal antibodies 2F5 and 2G12
26. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies
27. Neutralization sensitivity of cell culture-passaged simian immunodeficiency virus
28. Neutralizing and infection-enhancing antibody responses do not correlate with the differential pathogenicity of SIVmac239delta3 in adult and infant rhesus monkeys
29. Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120
30. Evidence for rapid selection and deletion of HIV-1 subpopulations in vivo by V3-specific neutralizing antibody: A model of humoral-associated selection
31. The C-terminal proline-rich tail of human immunodeficiency virus type 2 Vpx is necessary for nuclear localization of the viral preintegration complex in nondividing cells
32. Antibody neutralization-resistant primary isolates of human immunodeficiency virus type 1
33. Prevention of HIV-2 and SIVsm infection by passive immunization in cynomolgus monkeys
34. The complete nucleotide sequence of a pathogenic molecular clone of simian immunodeficiency virus
35. Human immunodeficiency virus (HIV)-positive sera obtained shortly after seroconversion neutralize autologous HIV type 1 isolates on primary macrophages but not on lymphocytes
36. Human immunodeficiency virus type 1 T-lymphotropic strains enter macrophages via a CD4- and CXCR4-mediated pathway: Replication is restricted at a postentry level
37. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: Progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population
38. Primate models for HIV vaccines
39. HIV-1 replication is controlled at the level of T cell activation and proviral integration
40. Characterization of monoclonal antibodies that distinguish simian immunodeficiency virus isolates from each other and from human immunodeficiency virus types 1 and 2
41. Macrophagetropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor
42. Use of coreceptors other than CCR5 by non-syncytium-inducing adult and pediatric isolates of human immunodeficiency virus type 1 is rare in vitro
43. Genotypic and phenotypic characterization of HIV-1 patients with primary infection
44. Plasmas from lymphocyte- and macrophage-tropic SIV mac-infected macaques have antibodies with a broader spectrum of virus neutralization activity in macrophage versus lymphocyte cultures
45. Failure of SIVmac to be neutralized in macrophage cultures is unique to SIVmac and not observed with neutralization of SHIV or HIV-1